Medacta International S.A.

Medacta International S.A. has 1 AI-enabled medical device on the FDA list. The first decision was on January 30, 2025 and the most recent on January 30, 2025 (MyShoulder Planner (5.3SSWPL)). Its most common review panel is Orthopedic (1 device).